FDA.reportPublic FDA data

BESIFLOXACIN Pharmacologic Class Indexing

Class set ID
66812db1-eb76-4faf-a130-31b1ecd4a873
Version
2
Effective date
20180813
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use BESIFLOXACIN OPHTHALMIC SUSPENSION safely and effectively. See full prescribing information for BESIFLOXACIN OPHTHALMIC SUSPENSION. BESIFLOXACIN OPHTHALMIC SUSPENSION, for topical ophthalmic use Initial U.S. Approval: 2009Bausch & Lomb Americas Inc. | Bausch & Lomb Incorporated202601121
These highlights do not include all the information needed to use BESIVANCE safely and effectively. See full prescribing information for BESIVANCE. BESIVANCE ® (besifloxacin ophthalmic suspension), for topical ophthalmic use Initial U.S. Approval: 2009Bausch & Lomb Incorporated2024070320
These highlights do not include all the information needed to use Besivance safely and effectively. See full prescribing information for Besivance. Besivance TM (besifloxacin ophthalmic suspension) 0.6% Sterile topical ophthalmic drops Initial U.S. Approval: 2009Physicians Total Care, Inc.200904011